History

TTI was founded as Transplantation Technologies Inc. by five research scientists and six research institutions located in Toronto and London, Ontario. As the name implies, the company’s research was focused on transplantation. TTI raised $13.5M in a series A financing in 2003-2004, and as the pipeline expanded in areas outside of transplantation, the Company changed its name to Trillium Therapeutics Inc. and remains known as TTI. The trillium (T. grandiflorum) is the provincial flower of Ontario, and was chosen to symbolically honour the company’s Ontario roots.